Moreover, the involvement of high-expression GRID2IP in tumor immunity was mainly related to T cells and innate immune cells, including T cells, CD8 + T cells, Macrophages, Neutrophils, DC cell, T helper cells, Th1 cells, Th2 cells. This evidence concerns the gene CD8A and neoplasm.